Close

Genesis Molecular AI

The AI Operating System for drug discovery
Founders:

Evan Feinburg

Founder / CEO, Genesis Molecular AI
About

Genesis Molecular is pioneering the use of AI to transform drug discovery and development, accelerating the creation of breakthrough medicines. By combining advanced deep learning technologies with molecular simulation, Genesis enables the discovery of novel therapies for challenging diseases with unprecedented speed and precision. 

The company’s platform is designed to identify and optimize drug candidates more efficiently, helping to address unmet medical needs and improve patient outcomes. With its innovative approach, Genesis is at the forefront of redefining what’s possible in modern medicine.

No items found.
Why we're excited

Latest blogs that include Genesis Molecular AI